Reuters logo
2 个月内
BRIEF-Glycomimetics announces proposed public offering of common stock
2017年5月22日 / 晚上8点21分 / 2 个月内

BRIEF-Glycomimetics announces proposed public offering of common stock

1 分钟阅读

May 22 (Reuters) - Glycomimetics Inc

* Glycomimetics announces proposed public offering of common stock

* Intends to offer and sell, subject to market conditions, 6 million shares of common stock in an underwritten public offering

* To use net proceeds to complete its ongoing phase 1/2 clinical trial of GMI-1271 in patients with acute myeloid leukemia (AML)

* Also intends to use net proceeds to complete its ongoing phase 1 clinical trial of GMI-1271 in patients with multiple myeloma (MM) Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below